Medication info
Akrab Tablet 30/20 mg

Akrab Tablet 30/20 mg

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate Granules›75mg / 1 tabletAtorvastatin Calcium Trihydrate›10.4mg / 1 tablet
Manufacturer / importer
Boryung Pharmaceutical Co., Ltd.
Appearance
Light green round film-coated tablet
Packaging
30 tablets/box [10 tablets/PTP*3]
Approval status
Active

MFDS item code 202003219 · Approved 2020.04.29 · Insurance code 641907650

Summary

Main use
Treatment of essential hypertension, improvement of dyslipidemia, prevention of cardiovascular disease
Who takes it
Adults
Adult dose
Take 1 tablet once daily with water, regardless of meals. It is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. This drug is for adults only. The dose should be individualized for each patient based on the effects and tolerability of each component, fimasartan and atorvastatin. Patients receiving fimasartan and atorvastatin as separate products may switch to this drug (a combination product with the same amount of each active ingredient) for convenience of administration. ○ Fimasartan 1. Adults The recommended dose of this drug is 30 ~ 60 milligrams once daily, regardless of meals. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. It is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks ~ 12 weeks. 2. Elderly patients No initial dose adjustment is required in elderly patients aged 70 years or younger. (See section 9. Administration to elderly patients under Precautions for use.) 3. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). In patients with severe renal impairment (creatinine clearance < 30 mL/min), initiate treatment at 30 milligrams once daily and do not exceed 60 milligrams per day. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. Do not administer this drug to patients with moderate ~ severe hepatic impairment (see sections 2. Patients in whom the drug must not be administered and 10. Administration to patients with hepatic impairment under Precautions for use). 5. Patients with decreased effective circulating blood volume (e.g., patients taking high doses of diuretics) For patients at high risk of hypotension, such as those with decreased effective circulating blood volume, an initial dose of 30 milligrams once daily is recommended. (See section 3. Patients in whom the drug should be administered with caution under Precautions for use.) ○ Atorvastatin Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The drug may be taken at any time of day, regardless of food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses of this drug should be individualized according to patient characteristics, taking into account the treatment goal and response. Analyze lipid levels within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and adjust the dose accordingly. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. - Patients with renal impairment: Renal disease does not affect atorvastatin plasma concentrations or its LDL cholesterol-lowering effect; therefore, no dose adjustment is required. - Elderly patients: The efficacy and safety in patients aged 70 years and older are similar to those in the general adult patient population.

Ingredients

Manufacturer
Boryung Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension, improvement of dyslipidemia, prevention of cardiovascular disease

  • Essential hypertension
  • primary hypercholesterolemia
  • mixed dyslipidemia
  • primary dysbetalipoproteinemia
  • elevated serum triglycerides
  • homozygous familial hypercholesterolemia
View approved original text

This medication is used for patients who need to take two drugs, Pimasartan and Atorvastatin, simultaneously. Pimasartan primarily helps to control blood pressure in patients with essential hypertension. Atorvastatin calcium reduces the risk of cardiovascular events such as myocardial infarction and stroke in patients at high risk of cardiovascular disease, and helps treat hyperlipidemia. In particular, it helps to lower cholesterol levels and increase HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia. The combination of these two drugs is used to effectively manage hypertension and the risk of cardiovascular disease.

How to take

Adult dose

Take 1 tablet once daily with water, regardless of meals. It is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. This drug is for adults only. The dose should be individualized for each patient based on the effects and tolerability of each component, fimasartan and atorvastatin. Patients receiving fimasartan and atorvastatin as separate products may switch to this drug (a combination product with the same amount of each active ingredient) for convenience of administration. ○ Fimasartan 1. Adults The recommended dose of this drug is 30 ~ 60 milligrams once daily, regardless of meals. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. It is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks ~ 12 weeks. 2. Elderly patients No initial dose adjustment is required in elderly patients aged 70 years or younger. (See section 9. Administration to elderly patients under Precautions for use.) 3. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). In patients with severe renal impairment (creatinine clearance < 30 mL/min), initiate treatment at 30 milligrams once daily and do not exceed 60 milligrams per day. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment. Do not administer this drug to patients with moderate ~ severe hepatic impairment (see sections 2. Patients in whom the drug must not be administered and 10. Administration to patients with hepatic impairment under Precautions for use). 5. Patients with decreased effective circulating blood volume (e.g., patients taking high doses of diuretics) For patients at high risk of hypotension, such as those with decreased effective circulating blood volume, an initial dose of 30 milligrams once daily is recommended. (See section 3. Patients in whom the drug should be administered with caution under Precautions for use.) ○ Atorvastatin Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. The drug may be taken at any time of day, regardless of food. 1. Hyperlipidemia The recommended initial dose is atorvastatin 10 mg once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses of this drug should be individualized according to patient characteristics, taking into account the treatment goal and response. Analyze lipid levels within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and adjust the dose accordingly. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer this drug in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. - Patients with renal impairment: Renal disease does not affect atorvastatin plasma concentrations or its LDL cholesterol-lowering effect; therefore, no dose adjustment is required. - Elderly patients: The efficacy and safety in patients aged 70 years and older are similar to those in the general adult patient population.

Precautions

This medication may cause serious harm or death to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters. Therefore, use should be discontinued immediately upon confirmation of pregnancy. This medication should not be used in patients with impaired liver function, muscle disease, or certain genetic lactose intolerance. Patients with a history of alcohol abuse or liver disease, the elderly, and those with impaired kidney function should take this medication with increased caution, and close monitoring by a physician may be required if necessary. This medication may cause muscle-related side effects such as myalgia, muscle weakness, and muscle damage; therefore, if severe or persistent muscle pain occurs, the physician should be notified immediately. Since this medication may cause blood pressure to drop too low, if symptoms of hypotension occur, immediate consultation with healthcare professionals is advised, especially for patients taking diuretics who should be particularly careful. During the use of this medication, regular liver function tests and blood tests are important to check for liver damage or muscle damage. Interactions may occur when taken with other medications, so it is essential to inform the physician or pharmacist of any other medications being taken. This medication may cause drowsiness or dizziness when driving or operating dangerous machinery, so caution is necessary. Women planning to become pregnant should consult a physician before taking this medication and should use appropriate contraception. Breastfeeding women should discuss with the physician whether to discontinue breastfeeding or the medication, as this medication may affect the baby. Safety and efficacy in children and adolescents under 18 years have not been established, and use should be avoided. In case of overdose, symptoms such as hypotension, palpitations, and bradycardia may occur, and immediate emergency treatment should be sought. This medication should be kept out of reach of children and stored in its original container to prevent misuse or degradation in quality.

Side effects

  • Headache
  • dizziness
  • increased serum creatine phosphokinase
  • abnormal liver enzyme levels
  • elevated ALT
  • increased serum lactate dehydrogenase
  • elevated liver enzyme levels
  • hypokalemia
  • fatigue
  • edema
Show 221 more
  • myalgia
  • hypertension
  • premature ventricular contractions
  • syncope
  • sedation
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • epigastric pain
  • weakness
  • foreign body sensation
  • decreased platelet count
  • cough
  • muscle contraction
  • musculoskeletal stiffness
  • pruritus
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • elevated liver enzyme levels
  • thrombocytopenia
  • allergic reactions
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual disturbances
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • hair loss
  • vascular edema
  • angioedema
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • weakness
  • fatigue
  • chest pain
  • peripheral edema
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
  • loss of appetite
  • constipation
  • abdominal bloating
  • diarrhea
  • abdominal pain
  • belching
  • pancreatitis
  • pharyngolaryngeal pain
  • epistaxis
  • insomnia
  • nightmares
  • perceptual disturbances
  • sensory loss
  • dysgeusia
  • amnesia
  • peripheral neuropathy
  • arthralgia
  • limb pain
  • muscle cramps
  • joint swelling
  • back pain
  • muscle fatigue
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • anaphylaxis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function tests
  • oral bleeding
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • melena
  • gingival bleeding
  • postprandial urgency
  • bronchitis
  • pneumonia
  • shortness of breath
  • asthma
  • pulmonary granuloma
  • abnormal chest X-ray
  • bronchitis
  • osteoarthritis
  • muscle weakness
  • tendinitis
  • osteomyelitis
  • shoulder rotator cuff syndrome
  • lateral epicondylitis
  • synovitis
  • sciatica
  • jaw pain
  • arthrosis
  • osteoporosis
  • carpal tunnel syndrome
  • pulmonary tuberculosis
  • axillary pain
  • periorbital edema
  • allergy
  • chills
  • exacerbation of low back pain
  • nasal polyps
  • peripheral edema
  • facial edema
  • fever
  • neck and shoulder pain
  • pharyngitis
  • upper respiratory infection
  • sputum
  • rhinitis
  • epistaxis
  • sensory disturbances
  • numbness
  • tremors
  • generalized muscle hypertonia
  • anxiety
  • memory impairment
  • loss of appetite
  • gastroesophageal reflux
  • gastritis
  • diarrhea
  • functional gastrointestinal disorder
  • gastroenteritis
  • increased urination
  • urinary incontinence
  • difficulty urinating
  • hyperlipidemia
  • dyslipidemia
  • hypoglycemia
  • tachycardia
  • purpura
  • fatty liver
  • localized inflammation
  • soft tissue infection
  • lymphadenopathy
  • postoperative pain
  • recurrent cancer
  • fall
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronitis
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal canal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • worsening cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colorectal carcinoma
  • neoplasm of unspecified type
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • fibrosing alveolitis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • exacerbation of low back pain
  • osteoarthritis
  • arthrosis
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • elevated blood pressure
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • epilepsy
  • polyneuropathy
  • hemiparesis
  • dementia
  • Parkinson's syndrome
  • gait disturbance
  • optic nerve damage
  • optic neuritis
  • blepharospasm
  • facial pain
  • normal pressure hydrocephalus
  • vertebrobasilar artery syndrome
  • restless legs syndrome
  • ischemic neuropathy
  • sensory disturbances
  • tremors
  • spinal canal stenosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is also recommended to store it at room temperature between 1 degree and 30 degrees Celsius. Avoid very hot or very cold places.

Appearance and packaging

Appearance

Light green round film-coated tablet

Package unit

30 tablets/box [10 tablets/PTP*3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.